A novel protocol for the production of recombinant LL-37 expressed as a thioredoxin fusion protein

Sørensen, 2001, Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3, Blood, 97, 3951, 10.1182/blood.V97.12.3951 Dürr, 2006, LL-37, the only human member of the cathelicidin family of antimicrobial peptides, Biochim. Biophys. Acta, 1758, 1408, 10.1016/j.bbamem.2006.03.030 Wu, 2010, Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications, Int. J. Cancer, 127, 1741, 10.1002/ijc.25489 Nijnik, 2009, The roles of cathelicidin LL-37 in immune defences and novel clinical applications, Curr. Opin. Hematol., 16, 41, 10.1097/MOH.0b013e32831ac517 Méndez-Samperio, 2010, The human cathelicidin hCAP18/LL-37: a multifunctional peptide involved in mycobacterial infections, Peptides, 31, 1791, 10.1016/j.peptides.2010.06.016 Bucki, 2011, Cathelicidin LL-37, A multitask antimicrobial peptide, Arch. Immunol. Ther. Exp. (Warsz), 58, 15, 10.1007/s00005-009-0057-2 Hensel, 2011, LL-37 as a therapeutic target for late stage prostate cancer, Prostate, 71, 659, 10.1002/pros.21282 T. Leung, K. Ching, A. Kong, G. Wong, J. Chan, K. Hon, Circulating LL-37 is a biomarker for eczema severity in children, J. Eur. Acad. Dermatol. Venereol. (in press), doi: 10.1111/j.1468-3083.2011.04083.x. Ingham, 2007, Recombinant production of antimicrobial peptides in heterologous microbial systems, Biotechnol. Appl. Biochem., 47, 1, 10.1042/BA20060207 Li, 2008, RAPD: a database of recombinantly-produced antimicrobial peptides, FEMS Microbiol. Lett., 289, 126, 10.1111/j.1574-6968.2008.01357.x Li, 2011, Recombinant production of antimicrobial peptides in Escherichia coli: A review, Protein Expr. Purif., 80, 260, 10.1016/j.pep.2011.08.001 Li, 2009, Carrier proteins for fusion expression of antimicrobial peptides in Escherichia coli, Biotechnol. Appl. Biochem., 54, 1, 10.1042/BA20090087 Feng, 2003, E. coli-based production of recombinant FALL-39, Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, 20, 634 Moon, 2006, Expression and purification of a recombinant LL-37 from Escherichia coli, Biochim. Biophys. Acta, 1758, 1351, 10.1016/j.bbamem.2006.02.003 Yang, 2004, Expression of bioactive recombinant GSLL-39, a variant of human antimicrobial peptide LL-37, in Escherichia coli, Protein Expr. Purif., 37, 229, 10.1016/j.pep.2004.06.007 Li, 2006, Cloning, expression, isotope labeling, and purification of human antimicrobial peptide LL-37 in Escherichia coli for NMR studies, Protein Expr. Purif., 47, 498, 10.1016/j.pep.2005.10.022 Li, 2007, A novel method for purifying recombinant human host defense cathelicidin LL-37 by utilizing its inherent property of aggregation, Protein Expr. Purif., 54, 157, 10.1016/j.pep.2007.02.003 Y. Li, Expression Systems and Database for Biological, Structural and Bioinformatic Studies of Antimicrobial Peptides. Ph.D. Dissertation, University of Nebraska Medical Center, Omaha, NE. (UMI No. 3314590), 2008. Krahulec, 2010, High level expression and purification of antimicrobial human cathelicidin LL-37 in Escherichia coli, Appl. Microbiol. Biotechnol., 88, 167, 10.1007/s00253-010-2736-7 Ramos, 2010, Escherichia coli expression and purification of LL37 fused to a family III carbohydrate-binding module from Clostridium thermocellum, Protein Expr. Purif., 71, 1, 10.1016/j.pep.2009.10.016 Bommarius, 2010, Cost-effective expression and purification of antimicrobial and host defense peptides in Escherichia coli, Peptides, 31, 1957, 10.1016/j.peptides.2010.08.008 Johansson, 1998, Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37, J. Biol. Chem., 273, 3718, 10.1074/jbc.273.6.3718 Dorschner, 2001, Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus, J. Invest. Dermatol., 117, 91, 10.1046/j.1523-1747.2001.01340.x Piers, 1993, Recombinant DNA procedures for producing small antimicrobial cationic peptides in bacteria, Gene, 134, 7, 10.1016/0378-1119(93)90168-3 Gibbs, 2004, Novel expression system for large-scale production and purification of recombinant class IIa bacteriocins and its application to piscicolin 126, Appl. Environ. Microbiol., 70, 3292, 10.1128/AEM.70.6.3292-3297.2004 Beaulieu, 2007, Production of active pediocin PA-1 in Escherichia coli using a thioredoxin gene fusion expression approach: cloning, expression, purification, and characterization, Can. J. Microbiol., 53, 1246, 10.1139/w07-089 Feng, 2006, Fusion expression of bovine lactoferricin in Escherichia coli, Protein Expr. Purif., 47, 110, 10.1016/j.pep.2005.08.016 Zhou, 2007, High-level production of a novel antimicrobial peptide perinerin in Escherichia coli by fusion expression, Curr. Microbiol., 54, 366, 10.1007/s00284-006-0466-y